Steven B. Bernitz
Plus aucun poste en cours
Profil
Steven B.
Bernitz formerly worked at Organogenesis, Inc., as President & Chief Executive Officer from 1999 to 2002, Histogenics Corp., as President & Chief Executive Officer, Merck & Co., Inc., as Principal, Dyax Corp., as Principal, Coley Pharmaceutical Group, Inc., as Senior VP-Business & Commercial Development, Synta Pharmaceuticals Corp., as Chief Business Officer & SVP-Corporate Development in 2014, Concert Pharmaceuticals, Inc., as Chief Business Officer, McKinsey & Co., Inc., as Consultant, Monitor Co. Group GP LLC, as Principal, and Extera Partners LLC, as General Partner.
Mr. Bernitz received his Masters Business Admin degree from Northwestern University, undergraduate degree from Tufts University, and Masters Business Admin degree from Kellogg School of Management.
Anciens postes connus de Steven B. Bernitz
| Sociétés | Poste | Fin |
|---|---|---|
Synta Pharmaceuticals Corp.
 Synta Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Synta Pharmaceuticals Corp. discovers, develops and commercializes pharmaceutical products. It focuses on the research, development and commercialization of oncology medicines that provides treatment to cancer patients. The company is also developing a proprietary platform for delivery of anti-cancer drugs directly to tumor cells, known as Hsp90-inhibitor drug conjugates. Synta Pharmaceuticals was founded by Safi R. Bahcall and Lan-Bo Chen in March 2000 and is headquartered in Lexington, MA. | Investor Relations Contact | 27/06/2014 |
Organogenesis, Inc.
 Organogenesis, Inc. Medical SpecialtiesHealth Technology Organogenesis, Inc. designs and manufactures regenerative medical products. It offers Apligraf, a living cell-based product indicated for the treatment of venous leg ulcers and diabetic foot ulcers and Dermagraft, a product for the treatment of diabetic foot ulcers. The firm also provides bioactive wound healing, biosurgery, and aesthetic medicine containing living cells and natural connective tissues. The company was founded in 1985 and is headquartered in Canton, MA. | Directeur Général | 01/01/2002 |
Monitor Co. Group GP LLC
 Monitor Co. Group GP LLC Miscellaneous Commercial ServicesCommercial Services Monitor Co. Group LP provides strategic management consulting services. The firm also offers financial advisory and investment banking services through monitor merchant banking. The company was founded by Joseph B. Fuller and Michael B. Partner in 1983 and is headquartered in Cambridge, MA. | Corporate Officer/Principal | - |
Extera Partners LLC
 Extera Partners LLC Miscellaneous Commercial ServicesCommercial Services Extera Partners LLC provides business advisory services. It offers corporate and business development, product commercialization, and company turnarounds services. The firm specializes in the planning for and execution of strategic transactions with life science industry partners and financial investors across the globe. The company was founded by Vikas Goyal, Lothar Koob and Jonathan Reis in 2006 and is headquartered in Cambridge, MA. | Corporate Officer/Principal | - |
| CONCERT PHARMACEUTICALS, INC. | Corporate Officer/Principal | - |
Formation de Steven B. Bernitz
| Northwestern University | Masters Business Admin |
| Tufts University | Undergraduate Degree |
| Kellogg School of Management | Masters Business Admin |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| MERCK & CO., INC. | Health Technology |
| Entreprise privées | 9 |
|---|---|
Organogenesis, Inc.
Organogenesis, Inc. Medical SpecialtiesHealth Technology Organogenesis, Inc. designs and manufactures regenerative medical products. It offers Apligraf, a living cell-based product indicated for the treatment of venous leg ulcers and diabetic foot ulcers and Dermagraft, a product for the treatment of diabetic foot ulcers. The firm also provides bioactive wound healing, biosurgery, and aesthetic medicine containing living cells and natural connective tissues. The company was founded in 1985 and is headquartered in Canton, MA. | Health Technology |
Dyax Corp.
 Dyax Corp. Pharmaceuticals: MajorHealth Technology Dyax Corp. engages in discovery, development and commercialization of novel biotherapeutics. The company was founded by Henry E. Blair in 1989 and is headquartered in Burlington, MA. | Health Technology |
Coley Pharmaceutical Group, Inc.
 Coley Pharmaceutical Group, Inc. Pharmaceuticals: MajorHealth Technology Coley Pharmaceutical Group, Inc. manufactures drugs to treat chronic diseases. The company discovers and develops receptors therapeutic candidates for cancers, asthma, and allergic disorders. It was founded in 1997 and is headquartered in Wellesley, MA | Health Technology |
Synta Pharmaceuticals Corp.
Synta Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Synta Pharmaceuticals Corp. discovers, develops and commercializes pharmaceutical products. It focuses on the research, development and commercialization of oncology medicines that provides treatment to cancer patients. The company is also developing a proprietary platform for delivery of anti-cancer drugs directly to tumor cells, known as Hsp90-inhibitor drug conjugates. Synta Pharmaceuticals was founded by Safi R. Bahcall and Lan-Bo Chen in March 2000 and is headquartered in Lexington, MA. | Health Technology |
Concert Pharmaceuticals, Inc.
 Concert Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Concert Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company, which discovers and develops novel small molecule drugs through the use of deuterium technology. Its product candidates target a range of diseases including autoimmune disorders, inflammation, and central nervous system disorders. The company was founded by Richard H. Aldrich, Roger D. Tung and Christoph H. Westphal on April 12, 2006 and is headquartered in Lexington, MA. | Health Technology |
Histogenics Corp.
 Histogenics Corp. BiotechnologyHealth Technology Histogenics Corp. engages in the development, marketing, and commercialization of restorative cell therapies. Its regenerative medicine platform combines expertise in cell processing, scaffolding, tissue engineering, bioadhesives, and growth factors to provide solutions that can be utilized individually and in concert to treat musculoskeletal-related conditions. The company was founded on June 28, 2000 and is headquartered in Waltham, MA. | Health Technology |
McKinsey & Co., Inc.
 McKinsey & Co., Inc. Miscellaneous Commercial ServicesCommercial Services McKinsey & Co., Inc. provides management consulting services. It specializes in design, marketing and sales, analytics, operations, transformation and restructuring, risk, strategy and corporate finance, and sustainability and resource productivity. The company was founded by James O. McKinsey in 1926 and is headquartered in New York, NY. | Commercial Services |
Monitor Co. Group GP LLC
Monitor Co. Group GP LLC Miscellaneous Commercial ServicesCommercial Services Monitor Co. Group LP provides strategic management consulting services. The firm also offers financial advisory and investment banking services through monitor merchant banking. The company was founded by Joseph B. Fuller and Michael B. Partner in 1983 and is headquartered in Cambridge, MA. | Commercial Services |
Extera Partners LLC
Extera Partners LLC Miscellaneous Commercial ServicesCommercial Services Extera Partners LLC provides business advisory services. It offers corporate and business development, product commercialization, and company turnarounds services. The firm specializes in the planning for and execution of strategic transactions with life science industry partners and financial investors across the globe. The company was founded by Vikas Goyal, Lothar Koob and Jonathan Reis in 2006 and is headquartered in Cambridge, MA. | Commercial Services |
